EUVIMEDEUVIMED entdecken
Crossref

Cu‐Intercalated MoS 2 Nanosheets with Enhanced Antibacterial Activity for Treatment of Bacterial Keratitis

Huihui Chen, Xiao Hu, Bingying Hou, Liying Qin, Eve-Graciella M E K Kuete, Levinus Hendrik Koole iD

Small · 2025

DOI: 10.1002/smll.202410643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Huihui Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China. Hauptthemen laut MEDLINE: Molybdenum, Disulfides, Anti-Bacterial Agents, Copper. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Research Project of Wenzhou City, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial keratitis (BK) is a critical and sight‐threatening corneal infection that significantly impairs the quality of life. Due to the widespread antibiotic‐resistant microbes and the slow development in antibiotics, there is an increasingly growing demand to create new antimicrobial agents for the treatment of BK. Herein, copper‐intercalated molybdenum disulfide (Cu‐MoS 2 ) nanosheets are constructed by intercalating Cu into the interlayer structure of MoS 2 via intercalation chemistry, which not only introduces the Fenton reaction but also modulates the electronic structure of MoS 2 . Cu‐MoS 2 can convert H 2 O 2 into more toxic reactive oxygen species (ROS), thereby exhibiting excellent bactericidal performance against Staphylococcus aureus (S. aureus) , methicillin‐resistant Staphylococcus aureus (MRSA) and Escherichia coli (E. coli) at room temperature in the dark. Animal experiments indicated that Cu‐MoS 2 can effectively treat BK caused by MRSA. This work demonstrates that intercalation chemistry as a novel and effective strategy to tune MoS 2 as the antibacterial agent with no reliance on light that has great potential therapeutic effects on clinical drug‐resistant BK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MolybdenumDisulfidesAnti-Bacterial AgentsCopperKeratitisNanostructuresAnimalsMethicillin-Resistant Staphylococcus aureusEscherichia coliMicrobial Sensitivity TestsStaphylococcus aureusReactive Oxygen SpeciesHumans

Stichwörter der Autor:innen

Cu‐MoS2 nanosheetsROSbacterial keratitiselectronic structureintercalation chemistry

Substanzen

MolybdenumDisulfidesAnti-Bacterial Agentsmolybdenum disulfideCopperReactive Oxygen Species

Autor:innen und Institutionen

  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.

ORCID-Profile: Levinus Hendrik Koole

Förderung

  • Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
  • Research Project of Wenzhou City
  • Wenzhou Medical University
  • Eye Hospital Wenzhou Medical University

Zitieren

APA

Chen, H., Hu, X., Hou, B., Qin, L., Kuete, E. M. E. K., & Koole, L. H. (2025). Cu‐Intercalated MoS 2 Nanosheets with Enhanced Antibacterial Activity for Treatment of Bacterial Keratitis. Small. https://doi.org/10.1002/smll.202410643

Vancouver

Chen H, Hu X, Hou B, Qin L, Kuete EMEK, Koole LH. Cu‐Intercalated MoS 2 Nanosheets with Enhanced Antibacterial Activity for Treatment of Bacterial Keratitis. Small. 2025. doi:10.1002/smll.202410643

BibTeX
@article{Chen2025,
  author = {Chen, Huihui and Hu, Xiao and Hou, Bingying and Qin, Liying and Kuete, Eve-Graciella M E K and Koole, Levinus Hendrik},
  title = {Cu‐Intercalated MoS 2 Nanosheets with Enhanced Antibacterial Activity for Treatment of Bacterial Keratitis},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202410643}
}
Kostenlos starten →